UNSPSC 51263157: Bupranolol hydrochloride

This classification denotes a beta-adrenergic blocking agent with the molecular formula C14H22ClNO2.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier DTC2G3GDPL, chemically known as 2-propanol, 1-tert-butylamino-3-(6-chloro-m-tolyloxy)-, hydrochloride but more generally known as bupranolol hydrochloride, which bears US NIH Compound Identifier 27072. European Medicines Agency schedules Bupranolol hydrochloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB00903MIG.

Most nations, for tariff and trade purposes, schedule bupranolol hydrochloride under HS 29221980 and SITC 51461. As of Q4 2014, BUPRANOLOL HYDROCHLORIDE remains US FDA's Preferred Term for this commodity. SMILES: CC1CCC(C(C1)OCC(CNC(C)(C)C)O)CL.CL.

UNSPSC 51263157 Bupranolol hydrochloride is a Commodity code that nominally identifies a specific pharmaceutical active ingredient, but recent state and local solicitations under this code diverge sharply from that narrow scope. The single recent opportunity on record — Seminole County, Florida's IFB60459723LAS posted June 30, 2026 — solicits naloxone and drug deactivation systems for community health initiatives, not bupranolol. The mismatch between the code's nominal pharmaceutical designation and the actual procurement signals either a coding error in the source record or that state and local procurement offices are using this code for broader opioid-response or emergency-medicine supply categories. State and local buyers tagging opportunities to this code appear to include county health and community services departments focused on overdose response and harm reduction, though the data set is too sparse to characterize issuing-body patterns with confidence.

Seminole County, Florida represents the sole recent activity documented under the code. The IFB solicited 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford; the response deadline was July 26, 2023, and vendors were required to submit bids electronically through the county's e-Procurement Portal with all shipping and delivery costs included. No other recent state or local opportunities appear in the record under this code. The procurement emphasizes standard compliance requirements — E-Verify, drug-free workplace certification, workers' compensation, commercial general liability, and professional liability insurance — and was potentially funded through FEMA with attendant federal environmental compliance obligations. Given the limited recent activity and the disconnect between the code's pharmaceutical name and actual procurement scope, this code shows little decision-relevant signal for business development purposes at present.